News & Events
- News
- Webinars
- Events
Resource Library
Careers
Training

Top Bar

MENUMENU

About UsAbout Us
Our Services
- Discovery / Non-clinical
  - - - Go to Discovery / Non-clinical section >>
  - - - Strategy and Consulting
        Development Strategy and Gap Analysis
        Integrated Product Development
        Market Access Strategy
        Non-clinical Development Concept
        and Study Design
        Scientific Advice
        Scientific Due Diligence
        Statistical Services
        Toxicology Services
- Clinical Development
  - - - Go to Clinical Development section >>
  - - - Strategy and Consulting
        Artificial Intelligence and Data Science
        Clinical Program Development
        Orphan Drug Designation
        Pediatric Investigation Plan (PIP)
        Scientific Advice
        Statistical Services
      - Regulatory Affairs
        Clinical Trial Applications (CTA)
        Global Procedure Management
        Health Authority / Agency Interaction
    - - Pharmacovigilance
        Clinical Trial Safety Support
        Pharmacovigilance Consulting
      - Quality
        GxP Services
        IMP Management
        Interim / Contract QA
        Quality Systems
        Tech Transfer / Scale-up
        Vendor Management and Oversight
- Authorization / Approval
  - - - Go to Authorization / Approval section >>
  - - - Strategy and Consulting
        Market Access
      - Regulatory Affairs
        CMC Services
        Global Procedure Management
        Health Authority / Agency Interaction
        Marketing and Labeling Activities
        Scientific, Regulatory and Technical Writing
        Statistical Services
    - - Pharmacovigilance
        EU QPPV / National QPPV
        Pharmacovigilance Consulting
        Risk Management Support
      - Quality
        Commercialization Readiness
        GxP Services
        Interim / Contract QA
        PAI Readiness
        Validation
- Post-approval / Maintenance
  - - - Go to Post-approval / Maintenance section >>
  - - - Strategy and Consulting
        Environmental Risk Assessment
        Market Access
      - Regulatory Affairs
        CMC Services
        Global End-to-End Outsourcing
        Global Procedure Management
        Health Authority / Agency Interaction
        Marketing and Labeling Activities
        Mergers and Acquisitions (M&A) Transfers
        Toxicology Services
      - Pharmacovigilance
        Audit and CAPA Management
        EU QPPV / National QPPV
        ICSR Management
        Literature Screening
        Pharmacovigilance Systems
        Safety Writing (PSUR, RMP)
        Signal Management
    - - Quality
        Commissioning and Qualification
        Good Distribution Practice (GDP) Compliance
        GxP Services
        Interim / Contract QA
        Quality Systems
        Validation
        Vendor Audit
        Vendor Management and Oversight
      - Medical Affairs
        Medical Information
- Program Management
  - - - Go to Program Management section >>
      - Program Management
        Global End-to-End Outsourcing
        Global Procedure Management
        Integrated Product Development
        Mergers and Acquisitions (M&A) Transfers
- Featured Expertise
  - - - Industry Expertise
        Biopharmaceuticals
        Consulting
        Consumer Healthcare
        Generics
        Herbal Medicines
        Medical Device Services
        Medicinal Products
        Pharmaceutical
        Veterinary Drugs
    - - Service Expertise
        ATMP / Cell and Gene Therapy
        Brexit
        COVID-19 Support
        Drug Re-purposing / Value-added Medicines
        GxP Services
        Market Access
        Pharmacoepidemiology
        Statistical Services
        Supporting Rx to OTC switches
        Technology Enabled Services
Global ReachGlobal Reach
Contact usContact us
News & Events
Resource Library
Careers
Training

Home > News & Events > News

News

Webinar // Overview of the Biotech Drug Development Pathway

5th December 2018

Continued supply of medicines to patients in the UK post-Brexit

4th December 2018

Understanding the Impact of Culture and Behaviours on Data Integrity Compliance

28th November 2018

Pharmaceutical Serialisation – Are you Ready?

23rd November 2018

TRAC Services, part of PharmaLex UK, reach £40K in donations to charity

15th November 2018

Can an Appropriate Risk-Benefit Assessment Help Drug Availability?

15th November 2018

HPRA Guide Update to “Notification of Marketing Status of Human Medicines”

8th November 2018

PharmaLex and A.R.C. Pharma join to strengthen existing regulatory consulting capabilities in France

1st November 2018

HPRA Guide Update to “Batch-Specific Requests for Human Medicines”

1st November 2018

2 3 4 5 6 7 8

…9 10 11 12 13 …

14 15 16 17 18 19

prev next

Upcoming Webinars

September 29th, 2020

QbD and process Characterization

October 8th, 2020

Marketing a drug in France, what are the responsibilities of an exploitant?

December 8th, 2020

Applied AI for Pharmaceutical R&D

Upcoming Events

September 24 - 25th, 2020

Society of Quality Assurance (SQA) Virtual Meeting and Quality College 2020

October 5 - 7th, 2020

TOPRA Symposium 2020

Visit us at booth #37

Archive

USEFUL LINKS

Home
Contact us
Imprint
Data Protection
Terms and Conditions

RECENT TWEETS

Tweets by @PharmaLexGLOBAL

COVID-19 NEWSLETTER SIGN UP

WHAT OUR CLIENTS SAY

They are available when we need to talk to them despite any time zone differentials

Japan based medium sized company
Manager

ISO9001:2015 Logo

#AskTheExpert #TogetherBEYONDCOVID19

Select your state:

Please tick this box to agree to our Privacy Policy

Please tick this box if you agree to periodic updates from PharmaLex.
You can unsubscribe at any time at data.protection@pharmalex.com

Please leave this field empty.

If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

#TogetherBEYONDCOVID19

We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for

Please DO NOT send us event/conference information.
We will not respond and these will be deleted immediately.

Select your state:

Please tick this box to agree to our Privacy Policy

Please tick this box if you agree to periodic updates from PharmaLex.
You can unsubscribe at any time at data.protection@pharmalex.com

Please leave this field empty.

If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

This can be specific information about signing up to the newsletter.

Pellentesque lobortis, tellus at ultrices ullamcorper, lectus tellus consectetur lectus, id consequat leo quam quis eros. Mauris pellentesque tortor a augue pellentesque ultricies. Phasellus sit amet suscipit orci, vel dapibus ligula. Maecenas at pellentesque lectus, sit amet tristique felis. Integer fringilla risus ac neque mollis, at imperdiet lacus sodales. In vehicula orci sed vulputate interdum. Nunc sagittis non nunc eget sollicitudin.

Maecenas a mattis erat. Phasellus cursus erat non nisl pulvinar ultricies. Aenean id fringilla libero. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Morbi in ultrices elit. Suspendisse egestas hendrerit est. Integer pellentesque nisl ut justo tempus, nec suscipit dolor luctus. Cras vestibulum elementum tincidunt.

In compliance with the Spanish Law 15/1999, of Protection of Personal Data and in accordance with regulations approved by the Spanish RD 994/1999 inform you that your data will be part of a file located in Friedrichsdorf (Germany), whose ownership belongs to Pharmalex Spain S.L.U. The purpose of these data is the insertion in a potential job selection process. Inform the user that at any time may exercise their right of access, rectification, and deletion of data through email curriculum@pharmalex.com or to this postal address Pharmalex Spain. Coso 103, 50001 Zaragoza, Spain.

Strategy and Consulting

Strategy and Consulting

Regulatory Affairs

Pharmacovigilance

Quality

Strategy and Consulting

Regulatory Affairs

Pharmacovigilance

Quality

Strategy and Consulting

Regulatory Affairs

Pharmacovigilance

Quality

Medical Affairs

Program Management

Industry Expertise

Service Expertise

Webinar // Overview of the Biotech Drug Development Pathway

Continued supply of medicines to patients in the UK post-Brexit

Understanding the Impact of Culture and Behaviours on Data Integrity Compliance

Pharmaceutical Serialisation – Are you Ready?

Can an Appropriate Risk-Benefit Assessment Help Drug Availability?

CPhI India 2018

IABS 2018

BioWin Day 2018

HPRA Guide Update to “Notification of Marketing Status of Human Medicines”

PharmaLex and A.R.C. Pharma join to strengthen existing regulatory consulting capabilities in France

HPRA Guide Update to “Batch-Specific Requests for Human Medicines”